Related Experiment Video
Updated: Jun 1, 2026
11:33
Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Amiloride-sensitive sodium channels and pulmonary edema
Mike Althaus1, Wolfgang G Clauss, Martin Fronius
1Institute of Animal Physiology, Justus-Liebig University of Giessen, Wartweg 95, 35392 Giessen, Germany.
Pulmonary Medicine
|June 4, 2011
Summary
Sodium channels are crucial for clearing fluid from lung alveoli. Dysfunctional sodium channels can lead to pulmonary edema, suggesting they are potential therapeutic targets for lung fluid management.
Area of Science:
- Pulmonary Medicine
- Cell Physiology
- Molecular Biology
Background:
- Pulmonary edema involves alveolar flooding and impaired fluid clearance.
- Alveolar fluid clearance is regulated by sodium transport across the alveolar epithelium.
- Sodium channels in alveolar epithelial cells are key to this transport.
Purpose of the Study:
- To explain the role of sodium channels in alveolar fluid clearance.
- To investigate how sodium channel dysfunction contributes to pulmonary edema pathogenesis.
- To discuss sodium channels as potential therapeutic targets for pulmonary edema.
Main Methods:
- Review of physiological mechanisms of alveolar fluid clearance.
- Analysis of the role of sodium channels in epithelial transport.
- Discussion of the link between sodium channel deregulation and lung disease.
Main Results:
- Sodium channels are essential for normal alveolar fluid clearance.
- Altered sodium channel activity is implicated in the development of pulmonary edema.
- Targeting sodium channels may offer a treatment strategy for pulmonary edema.
Conclusions:
- Sodium channel function is critical for maintaining lung fluid balance.
- Dysregulation of sodium channels contributes to pulmonary edema.
- Sodium channels represent promising targets for treating pulmonary edema.
Related Concept Videos
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...